single-pathway drugs weight loss tirzepatide Explained: The Future of Management Tirzepatide for Medical Weight Loss

The paradigm shifted dramatically with the release of multi-society guidance in October 2024, endorsed by the ASA, American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, International Society of Perioperative Care of Patients with Obesity, and Society of American Gastrointestinal and Endoscopic Surgeons [10]

NICE National Institute for Health and Care Excellence guidance on weight management

Potential for unknown long-term side effects Currently, there is limited evidence regarding the long-term safety and effectiveness of microdosing protocols for tirzepatide

This leads to smoother blood sugar levels and, even better, decreases hunger

Vision Changes: Report any vision changes as this could indicate retinopathy